Skip to main content
MedPathMedPath Home
Clinical Trials/NL-OMON37512
NL-OMON37512
Recruiting
Phase 2

Attention Defficity Hyperactivity Disorder and fMRI neurofeedback: A randomized controlled trial on the effects of self-modulating anterior cingulate cortex activation levels. - ADHD and fMRI-neurofeedback

niversitair Medisch Centrum Sint Radboud0 sites0 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Not specified
Sponsor
niversitair Medisch Centrum Sint Radboud
Status
Recruiting
Last Updated
last year
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Interventional

Investigators

Sponsor
niversitair Medisch Centrum Sint Radboud

Eligibility Criteria

Inclusion Criteria

  • •1\.) Diagnosis of ADHD according to the DSM\-IV TR criteria
  • •2\.) fMRI screening criteria
  • •3\.) Age \> 18
  • •4\.) IQ \> 85
  • •5\.) Psychopharmaca\-naïve or \-free, or being on a fixed dose of medication for the study period

Exclusion Criteria

  • •1\.) Current diagnosis of one or more Axis I diagnosis other than ADHD according to the DSM\-IV TR criteria
  • •2\.) Other significant medical condition/ regular use of medication other than psychostimulants
  • •3\.) Participation in another clinical trial simultaneously

Outcomes

Primary Outcomes

Not specified

Similar Trials

Active, Not Recruiting
N/A
Attention Deficit Hyperactivity Disorder (ADHD) and opioid maintenance therapy.A randomized, placebo-controlled study of the efficacy of atomoxetine for treating adult ADHD in patients receiving opioid maintenance therapyPatients will be recruited from out-patient clinics treating opioid dependent patients with buprenorphine or methadone maintenance therapy. Patients will be screened for ADHD symptoms. Based on the screen results, patients will undergo medical and psychiatric assessment to identify those meeting the criteria for adult ADHD. Patients diagnosed with comorbid ADHD and opioid dependence will then be randomized into atomoxetine and placebo study groups.MedDRA version: 12.1Level: LLTClassification code 10064104Term: ADHD
EUCTR2010-019981-94-FIHUS/ Neuropsykiatrian poliklinikka30
Completed
Phase 1
erofeeback Training (NFT) of ADHD child at homeADHDADHD hyperactiveD046650
JPRN-jRCT1030220201Tazaki Miyako8
Not Yet Recruiting
Phase 3
Identification of Attention Deficit Hyperactivity Disorder using Parent-Teacher administered ADHD Rating Scale-IV among Pre-school going children to know the prevalence of this disorder in Belagavi city.
CTRI/2023/07/054991KAHER Institute Of Physiotherapy
Completed
N/A
Attention deficit hyperactivity disorder, developmental coordination disorder, and the cognitive orientation to daily occupational performance approach: Is there a role for diagnostic profiling and treatment to improve mental health outcomes?Attention Deficit Hyperactivity DisorderDevelopmental Coordination DisorderMental Health - Other mental health disordersPhysical Medicine / Rehabilitation - Occupational therapy
ACTRN12618001972213a Trobe University19
Completed
Phase 3
Management of Attention - Deficit / Hyperactivity Disorder (ADHD) in Childern through AYURVEDA
CTRI/2019/01/017327Director IPGT and RA GAU Jamnagar40